Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1993 1
1994 2
1995 1
1996 2
1998 1
1999 5
2000 3
2001 4
2003 1
2005 4
2006 1
2007 1
2008 1
2009 3
2010 1
2011 1
2012 3
2013 3
2014 2
2015 1
2016 1
2017 1
2019 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J, Hamsikova E, Ludvikova V, Vydrova J, Traboulsi J, Vencalek O, Lukeš P, Tachezy R. Smahelova J, et al. Among authors: ludvikova v. JAMA Otolaryngol Head Neck Surg. 2022 Jul 1;148(7):654-661. doi: 10.1001/jamaoto.2022.1190. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35653138 Free PMC article. Clinical Trial.
HPV persistence and its oncogenic role in prostate tumors.
Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, Svec A, Urban M, Hamsikova E. Tachezy R, et al. Among authors: ludvikova v. J Med Virol. 2012 Oct;84(10):1636-45. doi: 10.1002/jmv.23367. J Med Virol. 2012. PMID: 22930513
Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT.
Šťastná-Marková M, Hamšíková E, Hainz P, Hubáček P, Kroutilová M, Kryštofová J, Ludvíková V, Musil J, Pecherková P, Saláková M, Šroller V, Vydra J, Němečková Š. Šťastná-Marková M, et al. Among authors: ludvikova v. Vaccines (Basel). 2021 Oct 22;9(11):1226. doi: 10.3390/vaccines9111226. Vaccines (Basel). 2021. PMID: 34835157 Free PMC article.
Prospective study on cervical neoplasia IV. Presence of HPV antibodies.
Vonka V, Hamsíková E, Kanka J, Ludvíková V, Sapp M, Smahel M. Vonka V, et al. Among authors: ludvikova v. Int J Cancer. 1999 Jan 29;80(3):365-8. doi: 10.1002/(sici)1097-0215(19990129)80:3<365::aid-ijc5>3.0.co;2-c. Int J Cancer. 1999. PMID: 9935175 Free article.
Markers of HPV infection and survival in patients with head and neck tumors.
Koslabova E, Hamsikova E, Salakova M, Klozar J, Foltynova E, Salkova E, Rotnaglova E, Ludvikova V, Tachezy R. Koslabova E, et al. Among authors: ludvikova v. Int J Cancer. 2013 Oct 15;133(8):1832-9. doi: 10.1002/ijc.28194. Epub 2013 May 2. Int J Cancer. 2013. PMID: 23564321 Free article.
47 results